Patent · US Active

Factor VIII: remodeling and glycoconjugation of factor VIII

US8076292B2 · kind B2 · utility

6Cited by

159References

110Claims

0Family size

Assignee

Novo Nordisk A/S · DK

Inventors

Shawn DeFrees · North Wales, US
David A. Zopf · Strafford, US
Robert J. Bayer · San Diego, US
Caryn Bowe · Doylestown, US
David Hakes · Willow Grove, US
Xi Chen · Newton, US

Key dates

Filing date	Dec 21, 2006
Grant date	Dec 13, 2011
Priority date	—
Expiry date	Feb 19, 2030

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K38/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention includes methods and compositions for remodeling a peptide molecule, including the addition or deletion of one or more glycosyl groups to a peptide, and/or the addition of a modifying group to a peptide.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.